KMTS: SEC Form 144 filed by Kestra Medical Technologies Ltd.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for KMTS
Across the 25 sessions after earlier KMTS headlines, the stock closed higher 13 times and lower 12 times, with a median move of 3.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | KMTS | SPY |
|---|---|---|---|
| Oct 20, 2026 | Evercore ISI initiated coverage on Kestra Medical Technologies with a new price target | -3.7% | +0.3% |
| Oct 1, 2026 | Kestra Medical Technologies Earns Five-Star Rating on Newsweek’s List of America’s Greatest Mid-Market Companies | -4.2% | +0.2% |
| Sep 15, 2026 | Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | +4.7% | -0.5% |
| Sep 10, 2026 | Kestra Names Daniel Finney Vice President of Research & Development | -2.1% | -0.6% |
| Sep 1, 2026 | Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14 | -2.4% | -0.7% |
| Aug 26, 2026 | Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience | -1.3% | +0.0% |
Keep researching KMTS
- KMTS insider tradesEvery buy and sale reported by Kestra Medical Technologies Ltd. officers, directors and large holders.
- KMTS earnings historyPast Kestra Medical Technologies Ltd. earnings releases, newest first.
- KMTS financial statementsRevenue, profit, cash flow and balance sheet from Kestra Medical Technologies Ltd.'s SEC filings.
Quantisnow market dataNASDAQ
KMTS
Kestra Medical Technologies Ltd.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2025
Get push alerts for KMTS
Full KMTS profile on Quantisnow Follow KMTS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time